Pałasiewicz G, Sliwiński P, Zieliński J
Kliniki Chorób Płuc Instytutu Gruźlicy, i Chorób Płuc w Warszawie.
Pneumonol Alergol Pol. 1996;64(3-4):189-95.
We aimed to investigate relations between PAP increase on exercise and long-term evolution of pulmonary hypertension and survival. 43 COPD pts were investigated. Initially they with mild pulmonary hypertension and abnormally high increase in PAP on exercise (40 W, 5 min). All pts were followed-up for 3-5 years. During follow-up 21 pts. died (group I), mean survival time was 28 +/- 17 month, and 22 survived (group II), mean observation period was 59 +/- 22 month. Survivors were recatheterized after 3-7 yrs (mean 5 yrs). PAP increased by 3.4 +/- 4.9 mm Hg and correlated better with initial PAP (r = 0.91, p < 0.001) than with delta PAP on exercise (r = 0.61, p < 0.02). Survivors differed from dead in FEV1 (1.59 +/- 55 vs 1.17 +/- 0.33 L, p < 0.02), VC (3.54 +/- 1.0 vs 2.8 +/- 0.84 L, p < 0.02), resting PaO2 (39.1 +/- 9.0 vs 46.3 +/- 11.5 mm Hg, p < 0.05) resting heart rate (82.5 +/- 13.6 vs 93.8 +/- 16.1 beats/min p < 0.02) resting PAP (20.7 +/- 8.2 vs 32.3 +/- 13.2 mm Hg, p < 0.002), and resting PW (7.6 +/- 2.0 vs 11.6 +/- 7.4 mm Hg, p < 0.05).
我们旨在研究运动时肺动脉压(PAP)升高与肺动脉高压的长期演变及生存率之间的关系。对43例慢性阻塞性肺疾病(COPD)患者进行了研究。最初,他们患有轻度肺动脉高压,且运动时PAP异常大幅升高(40瓦,5分钟)。所有患者均随访3至5年。随访期间,21例患者死亡(第一组),平均生存时间为28±17个月,22例存活(第二组),平均观察期为59±22个月。存活者在3至7年后(平均5年)再次接受心导管检查。PAP升高了3.4±4.9毫米汞柱,与初始PAP的相关性(r = 0.91,p < 0.001)优于与运动时PAP变化量(delta PAP)的相关性(r = 0.61,p < 0.02)。存活者与死亡者在第1秒用力呼气容积(FEV1)(1.59±0.55对1.17±0.33升,p < 0.02)、肺活量(VC)(3.54±1.0对2.8±0.84升,p < 0.02)、静息动脉血氧分压(PaO2)(39.1±9.0对46.3±11.5毫米汞柱,p < 0.05)、静息心率(82.5±13.6对93.8±16.1次/分钟,p < 0.02)、静息PAP(20.7±8.2对32.3±13.2毫米汞柱,p < 0.002)以及静息肺楔压(PW)(7.6±2.0对11.6±7.4毫米汞柱,p < 0.05)方面存在差异。